Sildenafil fine granulesAlternative Names: Sildenafil granules; Viasin
Latest Information Update: 07 May 2014
At a glance
- Originator SAMA Pharmaceuticals
- Class Erectile dysfunction therapies; Phenyl ethers; Piperazines; Purines; Small molecules; Sulfones
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Erectile dysfunction
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 30 Jun 2012 Launched for Erectile dysfunction in South Korea (PO)